- March 24, 2026 - National survey shows patient expectations and perceptions of GLP-1s are evolving, and clearer education is shaping obesity treatment decisions
Mechanick JI, Harrell R, Allende-Vigo MZ, Alvayero C, Arita-Melzer O, Aschner P, et al
Maintaining muscle mass is key for sustaining a healthy metabolism and body composition long-term
This study of semaglutide demonstrates the effectiveness of a new pathway to reduce the excess risk associated with obesity of important and potentially deadly cardiovascular complications. While the weight-loss effects of semaglutide appear to occur primarily through appetite suppression, researchers say the drug has other actions that may benefit the heart, including lowering blood sugar, blood pressure and cholesterol levels, as well as reducing inflammation, and having beneficial effects on heart muscle and blood vessels.
Swallow the tablet whole with water
Two years ago, researchers examining the link between GLP-1 and substance abuse began to publish large, observational studies showing that patients taking GLP-1s for their prescribed purposes incidentally reported less alcohol, opioid, cannabis and cigarette use and had a lower risk of developing a substance use disorder